Home/Filings/4/0000899243-23-004184
4//SEC Filing

Caggiano Anthony 4

Accession 0000899243-23-004184

CIK 0001455365other

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 4:05 PM ET

Size

7.4 KB

Accession

0000899243-23-004184

Insider Transaction Report

Form 4
Period: 2023-02-03
Caggiano Anthony
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2023-02-03+94,40694,406 total
  • Award

    Stock Option (Right to Buy)

    2023-02-03+94,40694,406 total
    Exercise: $2.12Exp: 2033-02-03Common Stock (94,406 underlying)
Footnotes (2)
  • [F1]Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
  • [F2]The option vests 33.3% on February 3, 2024, with the remaining 66.7% vesting in 24 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting dates.

Issuer

COGNITION THERAPEUTICS INC

CIK 0001455365

Entity typeother

Related Parties

1
  • filerCIK 0001892981

Filing Metadata

Form type
4
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:05 PM ET
Size
7.4 KB